MedTrace Logo

Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application

NCT02758990 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-10-02

No results posted yet for this study

Summary

The purpose of this study is to study interactions between genes, lifestyle environmental factors like foods, nutritional supplements and non-invasive medical devices and health factors that can be measured without specialized medical equipment in order to develop lifestyle recommendations tailored to individual genetics for a host of common chronic health conditions.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin A

Subjects will be asked to increase vitamin A intake by 8000 International Units per day.

DIETARY_SUPPLEMENT

Vitamin B6

Subjects will be asked to increase vitamin B6 intake by 50 mg per day.

DIETARY_SUPPLEMENT

Vitamin C

Subjects will be asked to increase vitamin C intake by 500 mg per day.

DIETARY_SUPPLEMENT

Nicotinamide

Subjects will be asked to increase Nicotinamide intake by 500 mg per day.

DIETARY_SUPPLEMENT

Vitamin D3

Subjects will be asked to increase Vitamin D3 intake by 1000 International Units per day.

DIETARY_SUPPLEMENT

Vitamin E

Subjects will be asked to increase vitamin E intake by 400 International Units per day.

OTHER

Broccoli

Subjects will be asked to increase broccoli intake by 8 fluid ounces (\~91 grams) per day.

OTHER

Spinach

Subjects will be asked to increase spinach intake by 8 fluid ounces (\~30 grams) per day.

DIETARY_SUPPLEMENT

Caffeine

Subjects will be asked to increase caffeine intake by taking 200mg caffeine orally once per day.

OTHER

Coffee

Subjects will be asked to increase coffee intake by drinking 2 cups (177 mL each) of coffee per day.

DEVICE

Axon Eyewear

Subjects will be asked to utilize the therapeutic eyewear when exposed to bright or fluorescent light.

OTHER

Chocolate

Subjects will be asked to increase chocolate intake by eating 57g per day.

Sponsors & Collaborators

  • Verifomics LLC

    lead INDUSTRY

Principal Investigators

  • Brody Holohan, PhD · Verifomics LLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-11-23
Completion
2016-11-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758990 on ClinicalTrials.gov